MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.
about
Effects of Peptide on NK cell-mediated MHC I recognitionGene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell EpitopesKinetics of antigen expression and epitope presentation during virus infection.Chemical biology strategies for posttranslational control of protein function.Ubiquitous Autofragmentation of Fluorescent Proteins Creates Abundant Defective Ribosomal Products (DRiPs) for Immunosurveillance.Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia InfectionAmsterdamming DRiPs.Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responsesThe E3 ubiquitin ligase UBE3C enhances proteasome processivity by ubiquitinating partially proteolyzed substrates.Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.Re-examining class-I presentation and the DRiP hypothesisMHC structure and function - antigen presentation. Part 2I've got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.
P2860
Q26822893-B871AEE1-8401-48AC-A526-E066D8F142EDQ28647428-63C58BA9-9C6F-4D98-B717-B175E581CB3EQ34574829-AE471635-52CD-4626-9BD7-45E696BD1DB8Q35264368-ABE88FE1-49FD-4B40-9304-E3F01578A0C8Q35783188-B8E72CC7-2120-46DC-AC22-BC974B0F181EQ36513486-F5B9A9CA-E054-4CC4-BBC8-85600F437557Q36724559-770E99DD-3A2B-4619-B672-ED04A7F58946Q37146941-FCDB49E2-8130-4C77-8181-36F5B2B25EDEQ37348923-B87869C7-D200-4FD4-822D-82B1E5D7FCB0Q37644973-3A0C4B21-8ECA-4381-9C9E-E55A653F73AAQ37702916-03F5E868-1349-4246-BE87-AC48BB4FDFBEQ38390459-04336875-F0FD-406D-9F65-B4151D30544BQ38731152-6E4E5856-362D-4627-A124-081B8FCC40E4Q42174739-91298A3F-A842-4839-AD35-863B5BEBF6ADQ45355050-41BAE950-46BD-43F1-8DE2-59943BE94FE8Q47241385-FC5D5767-43E5-44DB-B342-EFA9BA6AFA28Q48244442-8175D99F-1CEC-436D-A57B-6F4BD8907A56
P2860
MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@ast
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@en
type
label
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@ast
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@en
prefLabel
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@ast
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@en
P2093
P2860
P356
P1476
MHC class I antigen processing ...... from cellular vs. viral mRNA.
@en
P2093
Aditi A Sharma
Brian P Dolan
Jack R Bennink
James S Gibbs
Tshaka J Cunningham
P2860
P304
P356
10.1073/PNAS.1112387109
P407
P577
2012-04-16T00:00:00Z